Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Liver Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT04039607
What this trial is testing

Nivolumab in Combination With Ipilimumab in Participants With Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Bristol-Myers Squibb 732
Testing effectiveness (Phase 2)Study completedNCT05166239
What this trial is testing

HAIC Combine With Lenvatinib and PD-1 Inhibitors for Advanced HCC With PVTT

Who this might be right for
Hepatocellular CarcinomaPortal Vein Thrombosis
Peking University 66
Testing effectiveness (Phase 2)Study completedNCT00004136
What this trial is testing

Heat Therapy in Treating Patients With Unresectable Primary or Metastatic Liver Cancer

Who this might be right for
Liver CancerMetastatic Cancer
M.D. Anderson Cancer Center 59
Testing effectiveness (Phase 2)WithdrawnNCT06994299
What this trial is testing

A Pilot Trial of Preoperative Irradiation With the STRIDE (Single Dose of Tremelimumab With Ongoing Durvalumab) Regimen (PRISM) for Resectable/Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma (HCC)
Weill Medical College of Cornell University
Testing effectiveness (Phase 2)Study completedNCT00040898
What this trial is testing

Sho-Saiko-To Following Removal of Liver Cancer By Embolization in Treating Patients With Liver Cancer That Cannot Be Surgically Removed

Who this might be right for
Liver Cancer
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)UnknownNCT02423239
What this trial is testing

Dexanabinol in Combination With Chemotherapy in Patients With Advanced Tumours

Who this might be right for
Hepatocellular CarcinomaPancreatic Cancer
e-Therapeutics PLC 112
Testing effectiveness (Phase 2)Study completedNCT03111732
What this trial is testing

Pembrolizumab, a Monoclonal Antibody Against PD-1, in Combination With Capecitabine and Oxaliplatin (CAPOX) in People With Advanced Biliary Tract Carcinoma (BTC)

Who this might be right for
Biliary Tract NeoplasmsCholangiocarcinomaBile Duct Cancer+2 more
National Cancer Institute (NCI) 11
Testing effectiveness (Phase 2)WithdrawnNCT04158700
What this trial is testing

LY3200882 and Pembrolizumab in Participants With Advanced Cancer

Who this might be right for
Advanced Cancer
Eli Lilly and Company
Testing effectiveness (Phase 2)Study completedNCT00154817
What this trial is testing

A Phase II Study of Radiotherapy for Locally Advanced Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
National Taiwan University Hospital 12
Early research (Phase 1)Study completedNCT01131689
What this trial is testing

Trial of S-1 in Combination With Sorafenib for Patients With Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Samsung Medical Center 20
Not applicableLooking for participantsNCT07173868
What this trial is testing

FDG PET-CT in Advanced Breast Cancer

Who this might be right for
Histologically Confirmed Metastatic or Locally Advanced Breast Cancer With no Radical Topical Treatment AvailableIf There is Liver Metastasis, Which the Researcher Believes Will be Difficult to Evaluate the Response Accurately With Bone Metastasis or CT
Samsung Medical Center 100
Large-scale testing (Phase 3)Study completedNCT01287585
What this trial is testing

Ph 3 ADI-PEG 20 Versus Placebo in Subjects With Advanced Hepatocellular Carcinoma Who Have Failed Prior Systemic Therapy

Who this might be right for
Hepatocellular Carcinoma
Polaris Group 636
Not applicableUnknownNCT05233358
What this trial is testing

HAIC Combined With Second-line "Target Immunity" for HCC With TACE Standard Treatment Low Response or Failure

Who this might be right for
Hepatocellular Carcinoma
The Central Hospital of Lishui City 176
Not applicableLooking for participantsNCT06251115
What this trial is testing

Clinical Study on the Safety and Efficacy of QY-1-T in the Treatment of HBV-associated Advanced HCC

Who this might be right for
Liver Cancer
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 9
Not applicableUnknownNCT06423144
What this trial is testing

PD-1/PD-L1 Inhibitors and Anti-angiogenic Therapy Combined With/Without TACE/HAIC in Patients With BCLC B/C Hepatocellular Carcinoma Beyond Up-to-7

Who this might be right for
Hepatocellular Carcinoma
Shanghai Zhongshan Hospital 150
Testing effectiveness (Phase 2)Looking for participantsNCT07105748
What this trial is testing

HAIC Combined With Camrelizumab Plus Rivoceranib for Advanced Mixed Hepatocellular-cholangiocarcinoma (HCC-CCA)

Who this might be right for
Mixed Hepatocellular-cholangiocarcinoma
Fudan University 45
Testing effectiveness (Phase 2)Looking for participantsNCT05377034
What this trial is testing

Multinational Phase II Trial to Compare Safety and Efficacy of SIRT (Y-90 Resin Microspheres) Followed by Atezolizumab Plus Bevacizumab, vs SIRT (SIRT-Y90) Followed by Placebo in Locally Advanced HCC Patients

Who this might be right for
Locally Advanced Hepatocellular Carcinoma
National Cancer Centre, Singapore 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT06239155
What this trial is testing

A Phase I/II Study of AST-3424 in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsHepatocellular Carcinoma
Ascentawits Pharmaceuticals, Ltd 51
Early research (Phase 1)Study completedNCT01008917
What this trial is testing

Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
University of California, San Francisco 25
Testing effectiveness (Phase 2)UnknownNCT05178043
What this trial is testing

GT90001 Plus Nivolumab in Patients With Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaHCC
Suzhou Kintor Pharmaceutical Inc, 5
Next Page